Tyra Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tyra Biosciences (TYRA).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

12Buy

Consensus RatingBuy# Analysts13Avg. Consensus PT$44Upside to Avg. PT+106.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 22, 2026	Oppenheimer	Mazahir Alimohamed	PT Cut	Outperform	$50→$40
Sep 22, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Cut	Buy	$30→$29
Sep 10, 2026	Wedbush	Robert Driscoll	Maintained	Outperform	$53
Sep 10, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Cut	Buy	$45→$30
Sep 4, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$45
Jun 17, 2026	Jones Trading	Matthew Murray	Initiate	Buy	$56
Jun 10, 2026	B of A Securities	Geoff Meacham	PT Raise	Buy	$37→$42
May 19, 2026	Wolfe Research	Kalpit Patel	Initiate	Peer Perform	—
May 14, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$45
Apr 15, 2026	Guggenheim	Brad Canino	Initiate	Buy	$54
Apr 6, 2026	Canaccord Genuity	John Newman	Initiate	Buy	$50
Mar 20, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$42→$56
Feb 24, 2026	Cantor Fitzgerald	Li Watsek	Initiate	Overweight	—
Feb 17, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Raise	Buy	$30→$45
Feb 13, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$37→$53
Feb 3, 2026	Oppenheimer	Matthew Biegler	PT Raise	Outperform	$36→$50
Feb 3, 2026	Jefferies	Maury Raycroft	PT Raise	Buy	$32→$43
Jan 28, 2026	Barclays	Eliana Merle	Initiate	Overweight	$59
Jan 23, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$33→$42
Dec 16, 2025	Wedbush	Robert Driscoll	PT Raise	Outperform	$30→$37

Analyst Ratings News

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

Oppenheimer analyst Mazahir Alimohamed reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and lowers the price target from $50 to $40.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $30 to $29.

Benzinga Newsdesk

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $53 price target.

Benzinga Newsdesk

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $45 to $30.

Benzinga Newsdesk

Why Is Tyra Biosciences Stock Sinking Wednesday?

Tyra Biosciences stock fell sharply as initial dabogratinib Phase 2 data showed a 57% complete response rate at 60 mg.

Vandana Singh

Tyra Biosciences Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tyra Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

Why Is Tyra Biosciences Stock Sinking Wednesday?

People Also Watch

People Also Watch

Tyra Biosciences Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tyra Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROOppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PROHC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PROWedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday

PROHC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30

Why Is Tyra Biosciences Stock Sinking Wednesday?

People Also Watch

People Also Watch

PRO
Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29

PRO
Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30